In December 2024, after a thorough review of extensive scientific data, the Supreme Court of Victoria ruled in favor of Bayer in a detailed 745-page judgement, finding that the weight of scientific evidence demonstrates that the Essure device is not defective. This judgement has not been appealed and the matter has now concluded, effectively bringing to a close all cases related to Essure in Australia.
 

“Bayer continues to stand behind the safety and efficacy profiles of Essure, which is supported by a robust body of scientific study data. This body of data includes the results of 10 clinical trials and more than 150 studies, conducted by Bayer and independent researchers over the past 20 years, and involving more than 280,000 women.”
 

“The health and wellbeing of women who rely on our products is our greatest priority. Women who currently have Essure may continue to confidently rely on the device. If a woman with Essure has questions or concerns about the device, then we encourage her to speak to her healthcare professional.”

_{^{Date of preparation: June 2025
Bayer Australia Ltd, 875 Pacific Highway, Pymble, NSW, 2073. ABN: 22 000 138 714 - COR-ESS-AU-0014-01}}